Health professionals’ evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer
- 335 Downloads
Increasingly, women are offered genetic testing shortly after diagnosis of breast cancer to facilitate decision-making about treatment, often referred to as ‘treatment-focused genetic testing’ (TFGT). As understanding the attitudes of health professionals is likely to inform its integration into clinical care we surveyed professionals who participated in our TFGT randomized control study. Thirty-six completed surveys were received (response rate 59 %), 15 (42 %) health professionals classified as genetic and 21 (58 %) as non-genetic. Mainly positive experiences with participating in the TFGT trial were reported. The high cost of testing and who could best deliver information about TGFT to the patient were raised as key constraints to implementation of TFGT in usual care. More non-genetic than genetic health professionals (44 vs 8 %) preferred that the surgeon provide the information for decision-making about TFGT. While costs of TFGT itself and the time and effort of staff involved were perceived barriers, as testing costs become lower, it is expected that TFGT will become a routine part of standard clinical care for patients at high genetic risk in the near future.
KeywordsOncology professionals Attitudes Genetic testing Breast cancer Diagnosis Treatment-focused genetic testing Rapid genetic counseling
This study was funded as part of a Priority-Driven Collaborative Research Scheme grant that was jointly supported by Cancer Australia, Cancer Council and the National Breast Cancer Foundation (ID 630405). Bettina Meiser is supported by a Career Development Fellowship Award from the National Health and Medical Research Council Australia and a Cancer Institute New South Wales Career Development Fellowship. Kirsten Douma is supported by a Fellowship Award from the Dutch Cancer Society (UVA 2011-4918). We thank the health professionals who participated in this study. We gratefully acknowledge the support and endorsement of the Psycho-oncology Cooperative Research Group (PoCoG) for this project.
Conflict of interest
No conflict of interest are reported.
- 4.Meiser B, Tucker K, Friedlander M, Barlow-Stewart K, Lobb E, Saunders C et al (2008) Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Res 10(6):216CrossRefPubMedCentralPubMedGoogle Scholar
- 8.Wevers MR, Aaronson NK, Verhoef S, Bleiker EM, Hahn DE, Kuenen MA et al (2014) Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial. Br J Cancer 110(4):1081–1087CrossRefPubMedCentralPubMedGoogle Scholar
- 10.Zilliacus E, Meiser B, Gleeson M, Watts K, Tucker K, Lobb EA et al (2012) Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer. Support Care Cancer 20(11):2949–2958CrossRefPubMedGoogle Scholar
- 14.Watts KJ, Meiser B, Mitchell G, Kirk J, Saunders C, Peate M et al (2012) How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer. BMC Cancer 12:320CrossRefPubMedCentralPubMedGoogle Scholar